Author:
Goyal Lokesh,Pandit Ramesh,Pandit Trupti,Ajmera Kunal,Lusins John O,Islam Shah
Reference13 articles.
1. Ivermectin | COVID-19 Treatment Guidelines. (2022). Accessed. June 21, 2022: https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/.
2. The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer;Yang SN;Antiviral Res,2020
3. Over 25 years of clinical experience with ivermectin: an overview of safety for an increasing number of indications;Kircik LH;J Drugs Dermatol,2016
4. Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice;Zhang X;Inflamm Res,2008
5. Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19;DiNicolantonio JJ;Open Heart,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献